Records containing: Restless Legs Syndrome

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

• CLINICAL_TRIALS study record update · 2016-09-21
  An Open-Label, Long-Term, Follow-Up Study To Determine The Safety, Tolerability, and Efficacy of Rotigotine Transdermal System As Monotherapy in Adolescents With Restless Legs Syndrome
• CLINICAL_TRIALS study record update · 2016-09-15
  A 12-week, Double-blind, Placebo-controlled, Parallel Group Study to Assess the Efficacy and Safety of Intermittent Dosing of Ropinirole in Patients With Restless Legs Syndrome (RLS)
• CLINICAL_TRIALS study record update · 2016-03-17
  Sleep Disorders Management, Health and Safety in Police
• CLINICAL_TRIALS study record update · 2016-02-04
  Long-term Study - Long-term Efficacy and Safety of Gabapentin Enacarbil in Japanese Restless Legs Syndrome Patients
• CLINICAL_TRIALS study record update · 2015-10-06
  An Open-label Clinical Study to Investigate Pharmacokinetics (PK) of Different Doses (0.125 mg, 0.25 mg, 0.5 mg) of Pramipexole Administered Once Daily Orally in Pediatric Patients Who Are Individually Optimized to Stable Pramipexole Doses for the Treatment of Idiopathic Restless Legs Syndrome (RLS)
• Organize your saved records without ads with Plus.
• CLINICAL_TRIALS study record update · 2015-07-14
  A Multicenter, Open-Label, 2-Group, Dose Escalation Study of Monotherapy Administration of Rotigotine in Pediatric Subjects With Idiopathic Restless Legs Syndrome
• CLINICAL_TRIALS study record update · 2015-06-30
  A Phase II, Six-week, Randomised, Comparative, Double-blind Study of Intravenous Iron Isomaltoside 1000 Versus Placebo in Subjects With Restless Leg Syndrome With a 3 Month Extension
• CLINICAL_TRIALS study record update · 2015-06-10
  Iron Sucrose In The Treatment of Restless Legs Syndrome (RLS): The Safety of Three Dose Regimens as Evaluated by Clinical Assessments
• CLINICAL_TRIALS study record update · 2015-04-23
  Effects of Gabapentin Enacarbil on Intensity of Cortical Arousal, Heart Rate, Blood Pressure and Anterior Tibialis EMG Responses Associated With PLMs During Sleep in Patients With RLS Using a Novel Computer Assisted Scoring System
• CLINICAL_TRIALS study record update · 2015-04-06
  Vitamin D in the Treatment of Primary Restless Legs Syndrome: 12 Weeks, Triple-blinded, Randomized, Placebo-controlled Trial
• CLINICAL_TRIALS study record update · 2015-01-07
  Thalamic and Anterior Cingulate Cortex GABA and Glutamate in Restless Legs Syndrome: A 1-HMRS Study
• CLINICAL_TRIALS study record update · 2014-11-17
  Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose, Parallel-Group Study to Compare the Efficacy, Tolerability, and Safety of 3 Doses of Gabapentin Enacarbil (GSK1838262) With Placebo in Treatment of Moderate-to-Severe Primary RLS
• CLINICAL_TRIALS study record update · 2014-11-03
  A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel-group, Polysomnography Study to Investigate Safety and Efficacy of the Rotigotine Transdermal Patch in Subjects With Restless Legs Syndrome and End-Stage Renal Disease Requiring Hemodialysis
• CLINICAL_TRIALS study record update · 2014-10-29
  ASP8825 Phase ⅡStudy-A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of ASP8825 in Patients With Restless Legs Syndrome
• CLINICAL_TRIALS study record update · 2014-10-15
  Oxidative Stress and Apelin Level in Willis Ekbom Disease
• CLINICAL_TRIALS study record update · 2014-09-25
  Sifrol® Onset of Action and Impact on RLS: A 12-week Observational Study in Patients With Primary RLS
• CLINICAL_TRIALS study record update · 2014-09-25
  Sifrol® (Pramipexole) Impact on RLS: A 12-weeks Observational Study in Patients With Primary RLS
• CLINICAL_TRIALS study record update · 2014-09-25
  A Multi-center, Double-blind, Randomized, Placebo-controlled, Two-arm, Parallel-group, Sleep Lab Trial to Investigate the Efficacy and Safety of Transdermal Rotigotine in Subjects With Idiopathic Restless Legs Syndrome
• CLINICAL_TRIALS study record update · 2014-09-25
  A Multi-center, Randomized, Double-blind, Placebo-controlled, Four-arm Parallel-group Trial to Investigate the Efficacy and Safety of Three Different Transdermal Doses of Rotigotine in Subjects With Idiopathic Restless Leg Syndrome
• CLINICAL_TRIALS study record update · 2014-09-25
  A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Five-Arm Parallel-Group Trial to Investigate the Efficacy and Safety of Four Different Transdermal Doses of Rotigotine in Subjects With Idiopathic Restless Legs Syndrome
• CLINICAL_TRIALS study record update · 2014-09-25
  An Open-Label Extension Trial to Investigate the Safety and Tolerability of Long-Term Treatment With Transdermal Rotigotine in Subjects With Idiopathic Restless Legs Syndrome
• CLINICAL_TRIALS study record update · 2014-08-29
  Survey on Long-Term Use of BI-Sifrol® Tablets in Patients With Restless Legs Syndrome
• CLINICAL_TRIALS study record update · 2014-08-26
  A Phase 3B, Double-Blind, Randomized, Placebo-Controlled Study of Rotigotine and Its Effect on All-Day Functioning and Quality of Life in Subjects With Moderate to Severe Idiopathic Restless Legs Syndrome
• CLINICAL_TRIALS study record update · 2014-08-15
  Non Interventional Observational Study to Collect Data for the Effect of Switching to Neupro® on Severity of Restless Leg Syndrome (RLS) Symptoms and Augmentation as Well as the Change in Treatment Regimen Used, in RLS Patients With Previous Augmentation
• CLINICAL_TRIALS study record update · 2013-12-18
  ClinicalTrials.gov study NCT01937169